OMRIX biopharmaceuticals


about us	products & technology	investor relations	partnering with OMRIX	careers

OMRIX - Home Page


	OMRIX is a commercial-stage company that aims to develop and market innovative biosurgical and passive immunotherapy products, utilizing its proprietary protein purification technology and manufacturing know-how. read more >>



	OMRIX has partnered its biosurgical product line for hemostasis with Johnson & Johnson’s Ethicon division, a leader in the market place. This partnership allows each company to do what it does best, utilizing OMRIX’s know-how and manufacturing capabilities, and leveraging Johnson & Johnson’s sales and marketing leadership. Learn more about OMRIX’s partnerships.
	read more >>

OMRIX highlights

2008-09-22- Omrix Biopharmaceuticals Completes Enrollment of Initial 90 Patients Needed to Conduct Interim Analysis in Fibrin Pad U.S. Phase II Clinical Trial

2008-09-15- Omrix Biopharmaceuticals to Webcast Presentation at UBS Global Life Sciences Conference

2008-08-11- Omrix Biopharmaceuticals Announces Second Quarter 2008 Financial Results

2008-08-11- OMRIX Biopharmaceuticals Appoints Asaf Alperovitz as Chief Financial Officer


	OMRIX is an international bioscience company pioneering innovative, life-saving products. Working at OMRIX offers many opportunities in terms of career growth, cutting edge product development, and a team atmosphere. We continually seek out smart driven individuals who want to join us in providing solutions to critical unmet medical needs.
	read more >>


terms of use \| privacy policy \| contact us \| sitemap \| prescribing info